晚期疾病的OPDM4患者的临床和病理特征
Haixia Tang1, Ying Xiong1, Kaiyan Jiang1
1Department of Neurology, the First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Muscle & nerve
|July 24, 2024
概括
第4类耳鼻节骨髓病变 (OPDM4) 是由RILPL1基因CGG重复扩张引起的. 晚期疾病表现出逐渐增长的肌肉衰弱,亡和核内,有助于诊断.
科学领域:
- 遗传学 遗传学 是一个
- 神经学 神经学
- 病理学 病理学 病理学
背景情况:
- 第4型眼角骨髓损伤 (OPDM4) 是一种罕见的遗传疾病.
- 它是由RILPL1基因的5' UTR中CGG重复扩张引起的.
- 有限的数据存在于OPDM4.4的高级阶段.
研究的目的:
- 研究OPDM4患者在晚期疾病阶段的临床和肌病学特征.
- 扩大对OPDM的表型谱的理解4.
主要方法:
- 研究了一种自体主导的OPDM4家族 (8个受影响,12个不受影响).
- 进行肌肉活检分析 (组织学,酶组织化学,免疫组织化学,电子显微镜).
- 进行了全外体测序和重复原始PCR (RP-PCR) 来识别遗传变异.
主要成果:
- OPDM4患者从20至30岁开始呈现逐渐疲软,到50至70岁时导致非行走状态.
- 晚期疾病包括,眼,消化不良和脱发性关节炎.
- 肌肉MRI显示严重的脂肪透;活检显示脂肪组织的替代和内核含 (eosinophilic,p62,甘氨酸,polyA-R1阳性).
- 在RILPL1的5' UTR中,RP-PCR证实了CGG重复扩张.
结论:
- 这项研究扩大了OPDM4.4已知的临床和放射性特征.
- 肌肉活检中的核内是高级OPDM4.4的重要诊断标志物.
相关概念视频
01:20COPD: Pathogenesis and Clinical Features
252
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
252
01:15Parkinson's Disease: Overview
512
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
512